HomeORGANIZATION
ORGANIZATION

Drug Pricing Rules Should Be Fundamentally Reviewed: JMA Chief
(Nov.28.2016)

The government should review the current drug pricing system on a fundamental level, Yoshitake Yokokura, president of the Japan Medical Association (JMA), said on November 25, touching on the recent high cost drug issue ...
(LOG IN FOR FULL STORY)